Renalytix plc
RENXF- Exchange
- OTC
- Industry
- Services-Medical Laboratories
- SEC CIK
- 0001811115
No open-market purchases or sales by Renalytix plc insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Other share classesRNLXY
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Renalytix plc insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Renalytix plc, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Mount Sinai Health System, Inc. | 10% Owner | 32,683,998 | Nov 5, 2024 | 0 |
| Icahn School Of Medicine At Mount Sinai | 10% Owner | 32,683,998 | Nov 5, 2024 | 0 |
| Mount Sinai Hospitals Group, Inc. | 10% Owner | 32,683,998 | Nov 5, 2024 | 0 |
| Mount Sinai Hospital | 10% Owner | 32,683,998 | Nov 5, 2024 | 0 |
| Jung Joel R | Interim Chief Financial Office | – | Jun 13, 2024 | 0 |
| Levangie Daniel J | Director | – | Nov 22, 2023 | 0 |
| Mills Christopher | Director, 10% Owner | – | Nov 22, 2023 | 0 |
| Doran Howard JR | Chief Business Officer | – | Nov 22, 2023 | 0 |
| Coste Catherine | Director | – | Nov 22, 2023 | 0 |
| Parikh Chirag R. | Director | – | Nov 22, 2023 | 0 |
| McLain Thomas H | President | – | Jul 11, 2023 | 0 |
| Sterling O. James | Chief Financial Officer | – | Jul 7, 2023 | 0 |
| Fleming Fergus | Chief Technical Officer | – | Jul 7, 2023 | 0 |
| McCullough James Renwick | Chief Executive Officer | – | Jul 7, 2023 | 0 |
| Donovan Michael J. | Chief Medical Officer | – | Jul 7, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
No insider trades match these filters.